Corix Bioscience, Inc. (OTCPK:CXBS) announced that it has entered into material definitive agreement of 333,334 common shares at a price of $0.30 per share for gross proceeds of $100,000 on April 20, 2018. The transaction will include participation from Danny Berry, an individual and accredited investor. The transaction is expected to close by April 24, 2018. The transaction was approved by the board of directors.